Cytokine profiles of preterm neonates with fungal and bacterial sepsis

Pediatric Research

Volumn 72, Issue 2, 2012, Pages 212-220

  Sood, Beena G ^a   Shankaran, Seetha ^a   Schelonka, Robert L ^b   Saha, Shampa ^c   Benjamin, Danny K ^d   Sánchez, Pablo J ^e   Adams Chapman, Ira ^f   Stoll, Barbara J ^f   Thorsen, Poul ^g   Skogstrand, Kristin ^h   Ehrenkranz, Richard A ⁱ   Hougaard, David M ^c   Goldberg, Ronald N ^d   Tyson, Jon E ^j   Das, Abhik ^c   Higgins, Rosemary D ^k   Carlo, Waldemar A ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c RTI INTERNATIONAL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g KOLDING HOSPITAL   (Denmark)

^h STATENS SERUM INSTITUT   (Denmark)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^k EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; STEROID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASSISTED VENTILATION; BACTEREMIA; BLOOD STAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRIED BLOOD SPOT; FEMALE; FUNGEMIA; HOSPITALIZATION; HUMAN; IMMUNOASSAY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN MORTALITY; NEWBORN SEPSIS; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; SECONDARY ANALYSIS; STEROID THERAPY; VAGINAL DELIVERY;

AREA UNDER CURVE; BACTEREMIA; CASE-CONTROL STUDIES; CYTOKINES; DRIED BLOOD SPOT TESTING; FUNGEMIA; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-18; MODELS, STATISTICAL; ROC CURVE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864339007     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.56     Document Type: Article

References (45)

1. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17:638-80, table of contents. (Pubitemid 38970686)
2. Kaufman DA, Cuff AL, Wamstad JB, et al. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. J Pediatr 2011;158:759-765.e1.
3. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91. (Pubitemid 34833012)
4. Stoll BJ, Hansen NI, Adams-Chapman I, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65. (Pubitemid 39491920)
5. Zeitoun AA, Gad SS, Attia FM, Abu Maziad AS, Bell EF. Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early-and late-onset neonatal sepsis. Scand J Infect Dis 2010;42:299-305.
6. Hohl TM, Rivera A, Pamer EG. Immunity to fungi. Curr Opin Immunol 2006;18:465-72. (Pubitemid 43947577)
7. Berger A. Th1 and Th2 responses: what are they? BMJ 2000;321:424.
8. Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 2008;13:170-7. (Pubitemid 351594768)
9. Ghilardi N, Ouyang W. Targeting the development and effector functions of TH17 cells. Semin Immunol 2007;19:383-93.
10. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004;190:624-31. (Pubitemid 38982105)
11. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:639-46. (Pubitemid 46785128)
12. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008;41:92-104.
13. Pappu BP, Angkasekwinai P, Dong C. Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines. Pharmacol Ther 2008;117:374-84.
14. Schelonka RL, Maheshwari A, Carlo WA, et al.; NICHD Neonatal Research Network. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine 2011;53:249-55.
15. Oguz SS, Sipahi E, Dilmen U. C-reactive protein and interleukin-6 responses for differentiating fungal and bacterial aetiology in late-onset neonatal sepsis. Mycoses 2011;54:212-6.
16. Caldas JP, Marba ST, Blotta MH, Calil R, Morais SS, Oliveira RT. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. J Pediatr (Rio J) 2008;84:536-42.
17. Ucar B, Yildiz B, Aksit MA, et al. Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis. Mediators Inflamm 2008;2008:737141.
18. Ng PC, Li K, Leung TF, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006;52:1181-9. (Pubitemid 43794433)
19. Hotoura E, Giapros V, Kostoula A, Spirou P, Andronikou S. Tracking changes of lymphocyte subsets and pre-inflammatory mediators in fullterm neonates with suspected or documented infection. Scand J Immunol 2011;73:250-5.
20. Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007;2007:31397.
21. Shouman B, Badr R. Regulated on activation, normal T cell expressed and secreted and tumor necrosis factor-alpha in septic neonates. J Perinatol 2010;30:192-6.
22. Ng PC, Li K, Chui KM, et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007;61:93-8. (Pubitemid 46352323)
23. Kater H, Weiss M, Willeitner AE, et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998;352:1271-7. (Pubitemid 28470340)
24. Gonzalez BE, Mercado CK, Johnson L, Brodsky NL, Bhandari V. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med 2003;31:60-8. (Pubitemid 36286027)
25. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13. (Pubitemid 36560569)
26. Cancelier AC, Petronilho F, Reinke A, et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatr Crit Care Med 2009;10:467-71.
27. Onal EE, Kitap F, Dilmen U, Adam B. Interleukin-6 concentrations in neonatal sepsis. Lancet 1999;353:239-40.
28. Hodge G, Hodge S, Haslam R, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin Exp Immunol 2004;137:402-7. (Pubitemid 39013088)
29. Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996;129:574-80. (Pubitemid 27490795)
30. Romagnoli C, Frezza S, Cingolani A, et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001;160:345-50. (Pubitemid 32449145)
31. Panero A, Pacifico L, Rossi N, Mancuso G, Stegagno M, Chiesa C. Interleukin 6 in neonates with early and late onset infection. Pediatr Infect Dis J 1997;16:370-5. (Pubitemid 27172956)
32. D̈lner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001;54:1251-7. (Pubitemid 34007346)
33. Laborada G, Rego M, Jain A, et al. Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. Am J Perinatol 2003;20:491-501. (Pubitemid 37493887)
34. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007;51:1139-47.
35. Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009;206:299-311.
36. Oppenheim JJ, Ruscetti FW. Cytokines. In: Parslow TG, Stites DP, Terr AI, Imboden JB, eds. Medical Immunology, 10th edn. New York: Lange Medical Books/McGraw-Hill, 2001:148-166.
37. Kingsmore SF, Kennedy N, Halliday HL, et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics 2008;7:1863-75.
38. Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S, Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008;55:219-23.
39. Wahl SM. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 2007;19:55-62. (Pubitemid 46073697)
40. Benjamin DK Jr, Stoll BJ, Gantz MG, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010;126:e865-73.
41. Sood BG, Madan A, Saha S, et al.; NICHD neonatal research network. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 2010;67:394-400.
42. Lagakos SW. The challenge of subgroup analyses-reporting without distorting. N Engl J Med 2006;354:1667-9.
43. Carlo WA, McDonald SA, Tyson JE, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr 2011;159:919-25.e3.
44. Skogstrand K, Ekelund CK, Thorsen P, et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 2008;336:78-84.
45. Skogstrand K, Thorsen P, Ngaard-Pedersen B, Schendel DE, Saensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005;51:1854-66. (Pubitemid 41368176)